AKRO
Akero Therapeutics
AKRO
AKRO
Delisted
AKRO was delisted on the 8th of December, 2025.
239 hedge funds and large institutions have $3.5B invested in Akero Therapeutics in 2025 Q1 according to their latest regulatory filings, with 76 funds opening new positions, 92 increasing their positions, 49 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
40% more call options, than puts
Call options by funds: $51.2M | Put options by funds: $36.6M
26% more funds holding
Funds holding: 190 → 239 (+49)
2.28% more ownership
Funds ownership: 106.28% → 108.56% (+2.3%)
Holders
239
Holding in Top 10
13
Calls
$51.2M
Puts
$36.6M
Top Buyers
| 1 | +$72.2M | |
| 2 | +$69.6M | |
| 3 | +$54M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$50.6M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$44.2M |
Top Sellers
| 1 | -$58.3M | |
| 2 | -$23.8M | |
| 3 | -$22.2M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$18.6M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$18.1M |